The former CEO of Valeant Pharmaceuticals has been ordered to submit to binding arbitration his dispute with the company over allegedly unpaid stock options.

J. Michael Pearson, who left the company after eight years in May 2016, claimed in a suit that the arbitration clause in his 2015 employment agreement was superseded by terms of his separation agreement, which did not require arbitration.